(12) Unlted States Patent
`(10) Patent No.:
`US 8,457,988 B1
`
`Reardan et al.
`(45) Date of Patent:
`*Jun. 4, 2013
`
`USOO8457988B1
`
`(54) SENSITIVE DRUG DISTRIBUTION SYSTEM
`AND METHOD
`
`(75)
`
`Inventors: Dayton T..Reardan, Shorewood, MN
`(US); PattlA- Engela Eagan,MN(US);
`Bob Gagne, St. Paul, MN (US)
`
`(73) Assignee: Jazz Pharmaceuticals, Inc., Palo Alto,
`CA (US)
`.
`.
`.
`.
`Subject to any d1scla1mer, the term of th1s
`patent is extended or adjusted under 35
`U.S.C. 15403) by 0 days.
`
`.
`( * ) Notlce:
`
`This patent is subject to a terminal dis-
`claimer.
`
`(21) App1.No.: 13/595,757
`
`(22)
`
`Filed:
`
`Aug. 27’ 2012
`
`5,737,539 A
`5,845,255 A
`5,924,074 A
`6,021,392 A
`6,045,501 A
`6,055,507 A
`6,112,182 A
`6,315,720 B1
`
`4/1998 Edelson et a1.
`12/1998 Mayaud
`7/1999 Evans
`tal.
`2/2000 L t
`4/2000 13:38:12: et al.
`4/2000 Cunningham
`8/2000 Akers et 31.
`11/2001 Williams et al.
`
`6,347,329 B1
`6,561,977 B2
`6,564,121 B1
`6,755,784 B2
`6,952,681 32
`7,058,584 B2
`7,668,730 B2
`7,765,106 B2
`7,765,107 B2
`7,797,171 B2
`
`2/2002 EVanS
`5/2003 Williams et a1.
`5/2003 Wallace et al.
`6/2004 Williams et a1.
`10/2005 McQuade et 31.
`6/2006 Kosinski et al.
`2/2010 Reardan et a1.
`7/2010 Reardan et al.
`7/2010 Reardan et a1.
`9/2010 Reardan et a1.
`(Continued)
`OTHER PUBLICATIONS
`
`NASCSA National Conference, Orphan Medical, Inc., (Nov. 2000),
`8
`.
`
`Related US. Application Data
`
`pgs
`
`(60) Division of application No. 13/013,680, filed on Jan.
`25, 2011, now abandoned, which is a continuation of
`application No. 12/704,097, filed on Feb. 11, 2010,
`now Pat. No. 7,895,059, which is a continuation of
`application No. 10/322,348, filed on Dec. 17, 2002,
`now Pat. No. 7,668,730.
`
`(51)
`
`(2012.01)
`
`Int. Cl.
`G06Q 10/00
`(52) US. Cl,
`USPC .................................... 705/2; 705/3; 600/300
`(58) Field of Classification Search
`USPC ........................................... 705/2 3~ 600/300
`See application file for complete search history.
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`3,556,342 A
`MD“ Guarr
`4,847,764 A
`7/1989 Halvorson
`4,976,351 A
`12/1990 Mangini et a1.
`
`(Continued)
`
`Primary Examiner 7 Lena Naj arian
`(74) Attorney, Agent, or Firm 7 Schwegman Lundberg &
`Woessner, RA.
`
`(57)
`
`ABSTRACT
`
`A drug distribution system and method utilizes a central
`pharmacy and database to track all prescriptions for a sensi-
`tive drug. Information is kept in the database regarding all
`physicians allowed tO prescribe the sensitive drug, and all
`patients receiving the drug. Abuses are identified by monitor-
`ing data in the database for Prescription patterns by physi-
`cians and prescriptions obtained by patients. Further verifi-
`cation is made that the physician is eligible to prescribe the
`drug by consulting a separate database, and optionally
`whether any actions are taken against the physician. Multiple
`controls beyond those for normal drugs are imposed on the
`distribution depending on the sensitivity of the drug.
`
`15 Claims, 16 Drawing Sheets
`
`83
`(208
`WWW WJRK RM
`
`
`
`mil—Emil?“
`’
`
`
`
`
`
`
`\\Qetagg$fig£w
`
`A MM AFFRWM FORW
`
`
`
`276 1/ E
`
`93. ms 70 IS 101m )0 010313943;
`.,/’/:/
`[/34 27:3
`
`
`I86
`IRE Ii) 13 LEW/CK?) E! A
`
`
`WWI/4W 8 lam/ED MT
`01E FAiiCNi‘S 1h WNW E
`[I W”
`
`
`
`
`ENE Rx MI WNW I0
`l5 WED [MK 10 THE MD
`
`MIG W11 A UM] {UTE/i
`”WEN!” THAT THE Rx
`CANNOT BE P1013311)
`
`
`
`
` PAW WWW; TIM Will
`mm1350610111it
`R: W01 BE PEDCESSW
`WE FEM t3 KSWUL‘TEDT
`
`cam ‘13
`Fame
`C—
`
`
`
`. Till WWW HOLDS NE
`: PATH“ Rx um. RECEMMG
`A CWO!“ NERO/AL F016!
`
`if MY 94331510141” M00115 AYE:
`
`: Rx 13yWDCE§SEE Ml) Till
`
` W 7 , 4,
`
`AMN 1001
`
`CBM ofU.S. Patent No. 8,457,988
`
`Page 1 of 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 1 of 27
`
`

`

`US 8,457,988 B1
`
`Page 2
`
`U.S. PATENT DOCUMENTS
`
`7,895,059 B2
`2001/0001144 A1
`2001/0042050 A1
`2001/0047281 A1
`2002/0010661 A1
`2002/0032581 A1
`2002/0032582 A1
`2002/0042725 A1
`2002/0042762 A1
`2002/0052762 A1
`2002/0161607 A1
`2002/0177232 A1
`2003/0033168 A1
`2003/0046110 A1
`2003/0050802 A1
`2003/0074225 A1
`2003/0093295 A1
`2003/0110060 A1
`2003/0127508 A1
`2003/0144876 A1
`2003/0160698 A1
`2003/0197366 A1
`2003/0229519 A1
`2003/0233256 A1
`2004/0008123 A1
`2004/0019567 A1
`2004/0019794 A1
`2004/0078237 A1
`2004/0107117 A1
`2004/0117126 A1
`2004/0122712 A1
`2004/0122713 A1
`2004/0162740 A1
`2004/0176985 A1
`2005/0090425 A1
`2005/0216309 A1
`2005/0222874 A1
`2010/0138237 A1
`2011/0119085 A1
`2012/0209623 A1
`
`2/2011 Reardan et a1.
`5/2001 Kapp
`11/2001 Fletcher et al.
`11/2001 Keresman, III et a1.
`1/2002 Waddington et a1.
`3/2002 Reitberg
`3/2002 Feeney, Jr. et al.
`4/2002 Mayaud
`4/2002 McQuade et al.
`5/2002 Kobylevsky et al.
`10/2002 Subich
`11/2002 Melker et al.
`2/2003 Califano et al.
`3/2003 Gogolak
`3/2003 Jay et al.
`4/2003 Borsand et a1.
`5/2003 Lilly et al.
`6/2003 Clementi
`7/2003 Jones
`7/2003 Kosinski et al.
`8/2003 Andreasson et al.
`10/2003 Kusterbeck
`12/2003 Eidex et al.
`12/2003 Cardenas et a1.
`1/2004 Carrender et a1.
`1/2004 Herceg et al.
`1/2004 Moradi et a1.
`4/2004 Kaafarani et a1.
`6/2004 Denny
`6/2004 Fetterman et a1.
`6/2004 Hill, Sr. et al.
`6/2004 Hill, Sr. et al.
`8/2004 Ericsson et al.
`9/2004 Lilly et al.
`4/2005 Reardan et al.
`9/2005 Reardan et al.
`10/2005 Reardan et al.
`6/2010 Reardan et al.
`5/2011 Reardan et al.
`8/2012 Reardan et al.
`
`OTHER PUBLICATIONS
`
`“An Interview with Orphan Medical about Xyrem”, http://www.
`talkaboutsleep. com/sleepdisorders/archives/Narcolepsyixyrem,
`interview.htm, (Feb. 12, 2001), 3 pgs.
`“L .8. Appl. No. 10/322,348, Advisory Action mailed Feb. 5, 2007”,
`3 pgs.
`“L .8. Appl. No. 10/322,348, Appeal Brief filed May 21, 2007”, 32
`Pg5~
`“L .8. Appl. No. 10/322,348, Examiner Interview Summary mailed
`Oct. 21, 2009”, 3 pgs.
`“L.S. Appl. No. 10/322,348, Final Office Action mailed Oct. 18,
`2006”, 14 pgs.
`“L.S. Appl. No. 10/322,348, Final Office Action mailed Dec. 29,
`2005”, 11 pgs.
`“L .8. Appl. No. 10/322,348, Non Final Office Action mailed Jun. 17,
`2005”, 26 pgs.
`“L .8. Appl. No. 10/322,348, Non Final Office Action mailed Jun. 19,
`2006”, 18 pgs.
`“L .8. Appl. No. 10/322,348, Non Final Office Action mailed Jun. 29,
`2005”, 12 pgs.
`“L .8. Appl. No. 10/322,348, Notice of Allowance mailed Dec. 31,
`2009”, 16 pgs.
`“L .8. Appl. No. 10/322,348, Preliminary Amendment mailed Sep.
`30, 2004”, 11pgs.
`“L .8. Appl. No. 10/322,348, Reply Brief filed Dec. 3, 2007”, 4 pgs.
`“L.S. Appl. No. 10/322,348, Response filed Jan. 17, 2007 to Final
`Office Action mailed Oct. 18, 2006”, 17 pgs.
`“L .8. Appl. No. 10/322,348, Response filed Mar. 29, 2009 to Final
`Office Action mailed Dec. 29, 2005”, 11 pgs.
`“L.S. Appl. No. 10/322,348, Response filed Aug. 8, 2006 to Non
`Final Office Action mailed Jun. 19, 2006”, 10 pgs.
`“L.S. Appl. No. 10/322,348, Response filed Sep. 29, 2005 to Non
`Final Office Action mailed Jun. 29, 2005”, 19 pgs.
`
`
`
`
`
`
`
`“L .S.Appl. No. 10/731,915, Non Final OfficeAction mailedAug. 12,
`2005”, 22 pgs.
`“L .8. Appl. No. 10/731,915, Non Final Office Action mailed Oct. 5,
`2004”, 21 pgs.
`“L.S. Appl. No. 10/731,915, Non Final Office Action Response
`mailed Feb. 2, 2005”, 17 pgs.
`“L .8. Appl. No. 10/979,665, Non-Final Office Action mailed Nov.
`17, 2009”, 19 pgs.
`“L.S. Appl. No. 10/979,665, Notice of Allowance mailed Apr. 30,
`2010”, 8 pgs.
`“L .8. Appl. No. 10/979,665, Preliminary Amendment filed Jun. 22,
`2006”, 7 pgs.
`“L .8. Appl. No. 10/979,665, PreliminaryAmendment mailed Nov. 2,
`2004”, 3 pgs.
`“L.S. Appl. \Io. 10/979,665, Response filed Mar. 11, 2010 to Non
`Final Office Action mailed Nov. 17, 2009”, 13 pgs.
`“L .8. Appl. No. 10/979,665, Response filed Jul. 14, 2009 to Restric-
`tion Requirement mailed Jun. 25, 2009”, 8 pgs.
`“L.S. Appl. \Io. 10/979,665, Restriction Requirement mailed Jun.
`25, 2009”, 7 pgs.
`“L .8. Appl. No. 11/097,651, Examiner Interview Summary mailed
`May 27, 2010”, 3 pgs.
`“L.S. Appl. \Io. 11/097,651, Final Office Action mailed Nov. 12,
`2009”, 14 pgs.
`“L .8. Appl. No. 11/097,651, Non-Final Office Action mailed Mar. 3,
`2010”, 19 pgs.
`“L .8. Appl. \Io. 11/097,651, Non-Final Office Action mailed May
`29, 2009”, 21 pgs.
`“L.S. Appl. \Io. 11/097,651, Notice of Allowance mailed Jul. 23,
`2010”, 9 pgs.
`“L.S.Appl. No. 11/097,651, PreliminaryAmendment mailedApr. 1,
`2005”, 6 pgs.
`“L.S. Appl. \Io. 11/097,651, Response filed Feb. 9, 2010 to Final
`Office Action mailed Nov. 12, 2009”, 11 pgs.
`“L .S.Appl. No. 11/097,65 1, Response filed Jun. 3, 2010 to Non Final
`Office Action mailed Mar. 3, 2010”, 12 pgs.
`“L.S. Appl. \Io. 11/097,651, Response filed Sep. 17, 2009 to Non
`Final Office Action mailed May 29, 2009”, 10 pgs.
`“L .8. Appl. No. 11/097,985, Non Final OfficeAction mailed Sep. 14,
`2009”, 22 pgs.
`“L .8. Appl. \Io. 11/097,985, Notice of Allowance mailed Mar. 10,
`2010”, 11 pgs.
`“L.S.Appl. No. 11/097,985, PreliminaryAmendment mailedApr. 1,
`2005”, 7 pgs.
`“L.S. Appl. No. 11/097,985, Response filed Nov. 3, 2009 to Non
`Final Office Action mailed Sep. 14, 2009”, 15 pgs.
`“L.S. Appl. No. 11/097,985, Supplemental Notice of Allowability
`mailed Jun. 29, 2010”, 3 pgs.
`“L .S.Appl. No. 12/704,097, Non-Final OfficeAction mailed Sep. 24,
`2010”, 5 pgs.
`“L .8. Appl. No. 12/704,097, Notice of Allowance mailed Dec. 21,
`2010”, 8 pgs.
`“L.S. Appl. No. 12/704,097, Response filed Nov. 4, 2010 to Non
`Final Office Action mailed Sep. 24, 2010”, 12 pgs.
`“L .8. Appl. No. 13/013,680, Response filed Jun. 12, 2012 to Restric-
`tion Requirement mailed Dec. 14, 2011”, 9 pgs.
`“L .8. Appl. No. 13/013,680, Restriction Requirement mailed Dec.
`14, 2011”, 7 pgs.
`“L .8. Appl. No. 13/013,680, Preliminary Amendment filed Jun. 13,
`2012”, 4 pgs.
`“Civil Docket”, Jazz Pharmaceuticals, Inc. v. Roxane Laboratories,
`Inc., (United States District Court, District of New Jersey Civil
`Action No. 2:10-CV—06108-ES-CLW), (Nov. 22, 2010), 15 pgs.
`“Complaint for Patent Infringement”, Jazz Pharmaceuticals, Inc. v.
`Roxane Laboratories, Inc., (United States District Court, District of
`New Jersey Civil Action No. 10-6108 (ES) (CLW)), (Nov. 22, 2010),
`14 pgs.
`“Diversion Prevention Through Responsible Distribution”, NADDI
`Regional Training, (May 2001), 12 pages.
`“Diversion Prevention Through Responsible Distribution”, NADDI
`Regional Training Tennessee, (Jun. 2001), 14 Pages.
`“Diversion Prevention Through Responsible Distributio ”
`National Conference, (Nov. 2001), 15 pages.
`AW?b01
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 2 of 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 2 of 27
`
`

`

`US 8,457,988 B1
`Page 3
`
`“Jazz Pharmaceuticals, Inc.’s Opening Markman Brief’, Jazz Phar—
`maceuticals, Inc. V. RoxaneLaboratories, Inc., United States District
`Court, District ofNew Jersey Civil Action No. 10-6108 (ES) (CLW),
`(Dec. 5, 2011), 34 pgs.
`“Jazz Pharmaceuticals, Inc.’s Responsive Markman Brief’, Jazz
`Pharmaceuticals, Inc. V. Roxane Laboratories, Inc., (United States
`District Court, District of New Jersey Civil Action No. 10-6108 (ES)
`(CLW)), (Feb. 21, 2012), 41 pgs.
`“Joint Claim Construction and Prehearing Statement”, Jazz Pharma—
`ceuticals, Inc. V. Roxane Laboratories, Inc., (United States District
`Court, District ofNew Jersey Civil Action No. 10-6108 (ES) (CLW)),
`(Oct. 21, 2011), 31 pgs.
`“Letter dated Oct. 14, 2010 from Randall S. Wilson (Roxane Labs) to
`Bruce C. Cozadd (Jazz Pharmaceuticals)”, Re: Patent Notice Pursu-
`ant to Section 505(b)(3)(B) [21 USC Sec. 355(b)(3)(B)], (Oct. 14,
`2010), 11 pgs.
`“Letter from Theodora McCormick to Magistrate Judge Cathy L.
`Weldor”, (w/ Exhibits), (Feb. 27, 2012), 60 pgs.
`“Letter from Theodora McCormick to Magistrate Judge Cathy L.
`Weldor”, (w/ Exhibits), (Mar. 19, 2012), 104 pgs.
`“Letter from Theodora McCormick to Magistrate Judge Cathy L.
`Weldor”, (Mar. 29, 2012), 4 pgs.
`“Peripheral and Central Nervous System Drugs Advisory Commit-
`tee”, Department of Health and Human Services Food and Drug
`Administration Center for Drug Evaluation and Research, Holiday
`Inn, Bethesda, Maryland, (Jun. 6, 2001), 7 pages.
`“Preliminary Amendment pursuant to 37 CFR Sec. 1.115”, U.S.
`Appl. No. 11/104,013, filed Apr. 12, 2005, 3 pgs.
`“Reply to Counterclaims”, Jazz Pharmaceuticals, Inc. V. Roxane
`Laboratories, Inc., United States District Court, District of New
`Jersey Civil Action No. 10-6108 (SDW) (MCA), (Feb. 7, 2011), 37
`Pg5~
`“Reply to Counterclaims”, Jazz Pharmaceuticals, Inc. V. Roxane
`Laboratories, Inc., (United States District Court, District of New
`Jersey Civil Action No. 11-660 (SDW) (MCA) Lead Action CV-10-
`6108), (Apr. 18, 2011), 6 pgs.
`“Roxane Laboratories, Inc.’s Answer, Affirmative Defenses and
`Counterclaims to Plaintiffs Complaint”, Jazz Pharmaceuticals, Inc.
`V. RoxaneLaboratories, Inc. , United States District Court, District of
`New Jersey Civil Action No. 10-6108 (ES) (CLW), (Dec. 29, 2010),
`21 pgs.
`“Roxane Laboratories, Inc.’s Initial Invalidity and Noninfringement
`Contentions Pursuant to Local Patent Rule 3.6”, Jazz Pharmaceuti—
`cals, Inc. V. RoxaneLaboratories, Inc., (United States District Court,
`District of New Jersey Civil Action No. 2: 10-cv-06108 (SDW)
`(MCA)), (Apr. 14, 2011), 317 pgs.
`“Roxane Laboratories, Inc.’s Opening Markman Brief in Support of
`Its Claim Constructions”, Jazz Pharmaceuticals, Inc. V. Roxane
`Laboratories, Inc., )United States District Court, District of New
`Jersey Civil Action No. 2.10-cv-06108 (ES) (CLW)), (Dec. 5, 2011),
`37 pgs.
`“Roxane Laboratories, Inc.’s Responsive Markman Brief in Support
`of Its Claim Constructions”, Jazz Pharmaceuticals, Inc. V. Roxane
`Laboratories, Inc., (United States District Court, District of New
`Jersey Civil Action No. 2: 10-cv-06108 (ES) (CLW)), (Feb. 21, 2012),
`27 pgs.
`“System for Thalidomide Education and Prescribing Safety (S.T.E.
`P.S.) Starter Kit”, Celgene Corporation, (2001), 103 pgs.
`Ukens, C., “Specialty Pharmacy”, Drug Topics, 144, (Jun. 5, 2000),
`40-47.
`
`“U.S. Appl. No. 13/592,202, Response filed Feb. 15, 2013 to Restric-
`tion Requirement mailed Jan. 16, 2013”, 8 pgs.
`“U.S . Appl. No. 13/592,202, Restriction Requirement mailed Jan. 16,
`2013”, 6 pgs.
`“Briefing Booklet for the Peripheral and Central Nervous System
`Drugs Advisory Committee Meeting”, Orphan Medical, Inc., (Jun. 6,
`2001), 353 pgs.
`“Civil Cover Sheet”, Jazz Pharmaceuticals, Inc. V. Amneal Pharma—
`ceuticals, LLC, (United States District Court, District of New Jersey,
`(Jan. 18, 2013), 2 pgs.
`“Complaint for Patent Infringement”, Jazz Pharmaceuticals, Inc. V.
`Amneal Pharmaceuticals, LLC, (United States District Court, Dis-
`trict ofNew Jersey, (Jan. 18,2013), 17 pgs.
`“Controlled Substances Act”, Drugs of Abuse, US. Department of
`Justice, Drug Enforcement Administration, (1997), 9 pgs.
`“Detailed Factual and Legal Basis ofNon-Infringement and/or Inval-
`idity”, Amneal Pharmaceuticals, LLC, (Dec. 12, 2012), 3 pgs.
`“Detailed Factual and Legal Basis ofNon-Infringement and/or Inval-
`idity”, Amneal Pharmaceuticals, LLC, (Dec. 7, 2012), 6 pgs.
`“Exhibits A-D”, Jazz Pharmaceuticals v Amneal Pharmaceuticals,
`LLC, (Jan. 18,2013), 151 pgs.
`“Exhibits D-G”, Jazz Pharmaceuticals v Amneal Pharmaceuticals,
`LLC, (Jan. 18,2013), 123 pgs.
`“Fed. R. Civ. P. Rule 7.1 Disclosure Statement”, (Jan. 18, 2013), 2
`Pg5~
`“Making Good in Your Own Mail-Order Business”, Changing
`TimesiThe Kiplinger Magazine, (Oct. 1980), 66-68.
`“Markman Opinion, filed Sep. 14, 2012, in the case ofJazz Pharma—
`ceuticals, Inc., Plaintifl, V. Roxane Laboratories, Inc., Defendant
`(United States District Court for the District of New Jersey, Civil
`10-6108 ES)”, (Sep. 14, 2012), 43 pgs.
`“Notice of Electronic Filing: Civil Inital Pleadings (Attorney/Credit
`Card) USE CASE 33-1”, US District Court, District of new Jersey
`[LIVE], (Jan. 18,2013), 2 pgs.
`“Notice ofParagraph IV Certification Concerning ANDA 203631 for
`Sodiium Oxybate Oral Solution, 500 mg/mL”, Amneal Pharmaceu-
`ticals, LLC, (Dec. 7, 2012), 4 pgs.
`“Notice ofParagraph IV Certification Concerning ANDA 203631 for
`Sodiium Oxybate Oral Solution. 500 mg/mL”, Amneal Pharmaceu-
`ticals, LLC, (Dec. 12, 2012), 4 pgs.
`“Peripheral and Central Nervous System Drugs Advisory Commit-
`teeiTranscrip ”, Department of Health and Human Services Food
`and Drug Administration Center for Drug Evaluation and Research,
`Holiday Inn, Bethesda, Maryland, (Jun. 6, 2001), 381 pgs.
`“Roxane Laboratories, Inc.’s Answer and Affirmative Defenses to
`Plaintiffs Complaint”, (Jan. 4, 2013), 8 pgs.
`“Roxane Laboratories, Inc.’s Answer, Affirmative Defenses and
`Counterclaims to Plaintiffs Complain ”, (Dec. 29, 2010), 21 pgs.
`“Roxane Laboratories, Inc.’s Answer, Affirmative Defenses and
`Counterclaims to Plaintiffs Complain ”, (Mar. 9, 2011), 13 pgs.
`“Roxane Laboratories, Inc.’s Answer, Affirmative Defenses and
`Counterclaims to Plaintiffs Complaint”, (Jun. 1, 2011), 12 pgs.
`“Roxane Laboratories, Inc.’s Answer, Affirmative Defenses and
`Counterclaims to Plaintiffs Complain ”, (Nov. 9, 2012), 18 pgs.
`“Xyrem Prescription and Distribution Process-Video Script”, (Feb.
`2, 2001), 10 pgs.
`Deutsch, Sheryl, “The Verification and Information-Gathering Pro-
`cess”, The Credentialing Handbook, Aspen Publishers, Inc., (1999),
`231-275.
`Mani, Ranjit, “Preliminary Clinical Safety Review of NDA No.
`21196”, Orphan Medical, Inc., (May 3,2001), 122 pgs.
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 3 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 3 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 1 of 16
`
`US 8,457,988 B1
`
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 4 of 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 4 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 2 of 16
`
`US 8,457,988 B1
`
`1113
`
`111111 31111118 :11
`
`
`
`11A:
`
`11131111911 113.3111
`
`f.3WW.A:wWWWWMWW.W:AM13:11
`
`§
`1
`. 31311111313211‘1111111{11112 31111“AAAAAA»
`
`
`
`
`AAAAAAA AAA AAAAAAAAA 1311121111AAA-AAAAAAA
`
`.
`W ,
`
`
`1 TI" ‘
`["1111111‘11111!'1.11157111113"1113111111111211151111““““1
`---l--i?§-?;Z?TwWM“1Tiiif“““““‘“=M
`
`
`
`11:1}
`
`
`
`21’1
`
`
`11111 1‘
`1115111313-
`AAAAAAAAA:
`
`“‘\ 31111815331
`
`_
`.
`.
`AAA-:3
`...
`'
`=
`.11‘31‘111111 1
`.
`T
`‘
`111111111,
`A:
`.
`,-
`.1.“ 11,1
`“1115“AK"?
`3
`
`
`
`
`
`11113131113111111131111 1.1-
`
`
`
`"M1111. 11111311511181111SE111113 812.5111“ 1‘11 1%
`
`i
`131 11E1‘A1’CA11. 11,19111 11) 1111
`
`1:113110 131311111
`
`
`
`
`
`
`‘\ 1.1139””’
`\Hrw
`115$
`..................................................1
`
`"~
`
`,
`
`“1:11 1111 AAAAAA AAA 1AA ‘CGP‘1’
`
`
`
`
`A
`,
`
`. AAA}AAA 11 “11311111? AAAA AA
`AAAA‘A-
`
`
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 5 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 5 of 27
`
`

`

`U.S. Patent
`
`Jun. 4, 2013
`
`Sheet 3 of 16
`
`US 8,457,988 B1
`
`5
`
`:3 BREE: SUCCESS
`PACKS ‘33552 5553?: 333%
`
`REL:
`5 :
`
`EEEEEE: LEE: 55.0:
`3
`
`I""""5555‘5535‘55333‘SWEE""":55"""I
`
`
`5? .5333? SESSEPLLNERY 33350358 535333
`
`......................................................
`
`338E337?EB 533E LEER GE}SALEREE ES
`WEED A535) EELE'LES33E){)3 E3333
`FOLLOE‘EEEG $338335:
`53x 53 ERGCESSEB 3.335} 35335
`--
`PEERLESS? 3:303:33‘33533 353E LELEfS
`P:3:)SRAEE ACTEVEEY
`53 EEC-3
`39333333333313) E5333
`~33:
`:3 ELLEMjE‘EFL).
`EL:
`5:
`
`I“:::::::::: )RE F6
`r»-EEL 53::\<;-'
`E53- E55»»5:5L5ESEEE E: 5ELECEEE5I
`EE-5.: CEEEEELEL:
`:2““ME
`
`WERE-m3\ 1""
`5
`33:5 U’EEE‘ELEOEL"
`533 (“5:3
`
`5
`2853M
`-.-....-..--.:3EES
`I? 8f}
`5 EL 5553:.»5“ 20::5EELEEE‘: :5
`
`E»Emu-$5,.E E:{3333:5331} 5E:55
`":55: :EE’EE ES 5555:::35:
`5E5 EEELLE‘S EL EMEH
`:5:5
`35$ .EEE’M}
`EL: PRQCESSE
`MCE: ELLE 5:: ELLE:
`
`
`,
`1:555:53: 5.555.:
`
`3HE EEEEEEELSE WELL:
`.5,~~~~~ CELL-EELS 8E5::‘EEEx};
`ELL 555)E555L::“::.: ELL:
`\\\\\\E5 EEEELEEE EL 5E5 ELSE,
`35:53 EL REBEL
`
`3: ELLE“: ~-
`-
`wt?L
`2 2
`E LEE
`5:5E ELLE:E2535 555:5): 55E 5
`PEEELLEE’S 33x ULEEEL LEVEL?5
`E ESEEREGE :5PR55:. LEELL5
`
`EEG: L::5EEE,IEE555BEESLEELEIII:
`
`
`2 :’6
`
`,
`
`3
`
`5
`
`
`
`5M:EEELEWE
`.5EEEEEEEE: EL:LEE-5:. 555:5:
`EL: LE5::L,EEEEEE3:::5
`.............5
`:5
`L---___________
`
`K‘.
`
`5"}
`¢§§a
`An.“
`
` 33 5535353.:5} 8535333 53} ME
`
`f: CSEER 3.53383
`53.535539 E53335
`
`ELYERAEEE E3353"
`3:55"E5::
`
`
`CELEEEEGE BEI ”ELSESSEE:
`
`
`5 ELL
`ELEL’ELEiss
`EEELE‘: LEEEEEEE 555:55. 3..
`E: BEEN-555 5:5 35555253533553 3:
`55E EEELEE E: 5E35ELEIEEE 5E
`
`{553.5385 EVE?“ E5:ELEEE
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 6 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 6 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 4 of 16
`
`US 8,457,988 B1
`
`
`
`.
`.. .
`.E.’ A!)
`
`
`
`
`
`
`,
`.w.
`..__.....W
`UHGH HECEEH! E)? EHE CUE’EHCE. ACEHCE‘EAE E:BREE:HEEH
`
`EHIEA:'HEEHHUHC’EHEEE EHE. PHAHEEACE’ EECHHE‘AH
`
`
`CCHTACHEEH PAEEEHEHE‘CHP‘IEE EHEII IEECEEHECEAE‘E"
`
`FC‘EEC! SEECEEGHS HE IEEEEIE’ALE?A!
`
`‘UH‘E ‘
`
`....I344
`H 3:]:
`r’HIE{HE EHE:\\:\EEG
`HEEII HEIEEEEE’E CE EEH HA!!!H3EAE IICQHEEEHEEEIE) AH!)
`-
`<1? GGAE:E: EEAEEHEAESJ~~~~~~~~~~~~~~~~~~~
`AHGEEEER (1.33.3.
`:3 s::3381:3! COEEHSE? EEEEI
`
`‘~:3:
`EEAEEEHE “3:333:35 :E‘EEEEEE 33 SEEEEEEJEEQWWW
`.._....
`.246
`EE'3
`
`mmv... my.mmm.n..“.“.“m{.l.“"““....
`
`‘EEEIH SEICEIEGEESI
`AIIEIEIH COHHEEHHC
`(HI EH.II
`‘:ICK
`IE HE!IE! EEEEI
`IIEEIEH IE
`, HHAHEEAC’E HIE!EHEEEEAH
`EHHwEEE: HES! CAELEHE!)!HIE EHAHEEACESEI HHS
`EEEIEE’EEHSEHE CHEER! CHEICEHESE AHCE'CEEHE’EEIES EHEI
`
` H83! EEC \{HE EC) EEC?
`
`..........Eff.EEEEEEE!:...‘.‘.ETEEEEEHE.T§§E.I-.‘.EE.?EE.E:.3_:EEHEH2.---
`24-8
`=EA.EAEHE‘E.IEI EABECATESEHCHEHIS HEAEIHEEC HATCH
`
`E
`‘EE’ECEEEAC CHE.EE’HSE HAS SHCCESSEHEUEY CGEEHEEEECH
`
`wuswwxm
`'
`INCL!EHEHCEEEEI HAEE CHEEE‘ECEEH
`
`
`E1133 TEEE. HAHEHE ES EHAEEH:.: UH HAS
`
`-
`33:3: PHEPEEAL 533%.: ”:13: 93::HES 3:3me :0:
`H.
`E
`EAE‘HE‘ HHS HE HE PE’I’RH‘E’" HE SHAW
`3:: 33:33:": 33:32:39.2: 9.3: (:3: HES Am BHSEAESS 0::
`3::
`a.
`.
`.
`.
`.
`FAHDECEPEE:3 HEEEEH:.€
`:33: 937533.233...
`HE:WH’I‘A:EKH.HCEAUHA~LHAVHFHHMHEHHHK’AHE
`E WEEHE’Q {)5SEQEEEE {353$} QEGE‘: Tag 3}H: 915.53%?
`
`33:0:3 EEEEEEH
`E-...-.--.._..Wmmwwwwm.
` THE PHAE‘HACSEEHH THE. Hx {WEEK
`E
`
`H! {HE‘S CKEAEE’E: A?! ”REESE HEEEEBEH
`
`'
`E
`
`{AERIEE’EMEIITEHEEE'IIIIEIIEIIEIIEEEIMTAEEHIIIII‘EIIIEIIWI:
`EIEEE. HEEAEEEEACE EI{EH H!!!“
`
`‘EIH ESE. HEEAEEE!) E!)
`
`«335
`
`TEE: GHEEGEEAE 3:31: 3:53 33:33 EHE HHAEEHAC‘: ’f
`
`32:3 3:: 3333:5330: CHEER
`
`NH! 3:31:33 3:33:13:ER: ES (2:3::: 30:3‘33{:3 333::
`______
`
`
`E-------
`3:»:333:3:313 33:3: 3:: 93::-
`.::2:::EEEAHEEHEIS
`3:32 am :5: s::33:
`EE: EESPS 5:33:55: 3:33:
`
`
`
`
`W“ W“ ”W“ ............E133:2 E3313,Mg....3:3: 3:::3:353......
`CA:
`‘3
`m «~-
`EMAE
`:335. 2::
`
`m
`
`‘
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 7 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 7 of 27
`
`

`

`U.S. Patent
`
`Jun. 4, 2013
`
`Sheet 5 of 16
`
`US 8,457,988 B1
`
`.323{333333 33333333
`
`
`
`
`
`
`.333 CA3.3 33:33:33 3
`33333333 .33 3
`
`
`
`.3333 3333 {3333.33333}"
`g
`3W333333333 333333 93333-3;
`
`
`
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 8 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 8 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 6 of 16
`
`US 8,457,988 B1
`
`3:40:12
`2 HR‘REEEE4.4.”: \
`
`4/
`
`
`
`g“ 4444 443444444: 444444
`“4444444,. 44444444444:4:
`4444444444 444 44444444:44 4444 4:
`
`
`
`€?{\\
`4:44444:44:44
`4:444:44:
`
`:4
`4:3:............................
`
`
`
`
`444443344444::3 4444 44444 44444444444444
`
`3444 44 44 44444444444444: ._
`E
`4: 4
`“4.44: 4.24445 444444444; 4444:
`
`
`
`
`4444444444444444:
`4
`44:44 :44:4444—444.4 444.4“ REE-1444:4444
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 9 0f 27
`
`
`ER: RRRRREI?
`4“
`444444 44444444”R4‘44444444
`SEEE‘RER?EEOR REE
`:44
`E? ERSERESS REY RR REE REX?
`
`ESE}SZRESS DRE
`R44. FREE? 43 444444444344:
`“:4.-
`3}?"
`H‘: ERR RSE RRCRR'G
`
`4
`4:44:
`ME RARRRC‘R?RE?“ REE R44 URL‘ER
`
`2R CREPE, CREWERG RE GREEK RURBER
`
`
`
`[T4144 44 44444 444
`
`:SE RESR’EGE R’E‘: 34.4} ERR REE EZRRE’RS
`4W 4
`www-mwww—MWNNEW
`
`1
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 9 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 7 of 16
`
`US 8,457,988 B1
`
`YEEE Y’AYYEYYY REYES YYYYRECLYESY LYY ELYYYEY EYEEEYY.
`
` ELLLYLSYY W386L‘HYEPYYYL LL};
`LLLS. LL LLLLLLEL.L
`SCREEYY LLLL
`L“EC.....:’22...2..............
`
`’LLLLLLLLLLLY’EYYY LLLLL ELYYBE’LYRLESS;
`E F'YYCLLLCYL
`
`
`:
`Y
`LLLLLLE LLSLLLL LL SYEZRCSE
`..
`
`
`YE}- REC-EYE LYCCYYYCLYYYLE “RCELCY
`
`
`
`RYE YYEYYEYYY YYYYYSL‘LYLE? U’LY‘EYl;
`SCYYC
`I
`RE}ELL LYLE
`
`
`
`E
`,er LL}
`{EYES \‘xi:\ KY}
`xx”
`c;
`LL; LLLLLLLE >...............................
`\i‘gERQfif?,
`.W
`\EYES
`m..-.......................................7....
`LLL: LLLLL
`LLLLLLL‘ L LLLL-L‘ LL CELL-é
`
`LL‘LLLL: LLL
`:inLYLLL LL—LL LLLLLLL
`LLLLOLS YLLE LCM
`
`
`”WY..........
`\L 444
`L
`YEYYCL
`\--------------------------w
`
`Yin,-
`
`EEYYE LLTLLLLL EYES? LLLL LLLLL YLYE M SLHLLLLELY
`LELLL LLELL?LEL’LLLE LLLLLLLL
`LL-{LLLCL
`.- E
`
`HEY): E
`Y3 LL:
`-------------------------W1: LL:.EEEEE LLLL ELL :>
`\\\x CRY?xxxxxx
`2
`2
`E
`45:3
`3552
`ELYLYY’EYYYY’S YYYSLRYLLC-
`SLECLL‘LLLSL Ya} CCYYYLYYY YE
`L------E‘L‘E‘YYL‘EYY“““““LYYL‘L‘EL‘LYEYEEY‘EYmsYYYY““““
`LLLLLLLL LL LLEYYYY gggLLLLE L-LL YEEE LLLLL LELLL
`Y
`:\3
`EMMY;EEYYE‘YYYESCYEEYL..........Y
`~
`L
`L
`, YEYYY. ELLEx. ELY)
`(ELLE EYE»WW L“"“‘“““'““‘”“'“‘“““““i“ W“
`LLLLLLLL L
`\\ EEE,,
`LLLLL LLLLLY‘YS EYYZCELLLLL EYYE my?“ ES LELELLELL
`
`
`
`L
`
`
`
`
`
`L~,’EYLLL3CYYC£EEEY~Y SYEYRYLYYYS A CCYERYLLYE YERYYRCYAE
`2E0REL. YCY YYYE :3YYLYRCA-CY YEYLYEY LY: L‘YY‘YEYCYLYYCLY YYYL‘YY
`THE RAYYEYL'YS REYYEY. RE'YYESY CAR BY. Y'YYGC
`
`YEY. E‘YYARYYYYEY YE}CYYYL‘YCYAYY L’YYLYYLCS ’2YYYY?
`SLHYYYJJUYY?
`SYYYYYYYEYYY {YY’2
`2
`“‘32
`Y -".YCY Y’CRI
`
`EEYYSYYYYSS EM 'YR YYYYE‘ Es
`’
`2
`'
`
`33 YY’L’LYYYY YE}
`SYYER YYY
`
`
`L
`
`PALYCYLLLY
`
`
`
`
`
`
`
`
`
`
`
`
`-
`
`
` ‘22YYYYYYELYYY (GREY?YSYYYE “L‘CYE .
`L-
`?YYOYYYYYIYYCR YYSE YYEYL’E
`.SYYYRYY..LLY CY YYYY’
`ELI‘ LAY’YCR YYYE REYY E’EJSYYYESS EYLY‘L’ YYYE YAYYEYYY
`S LYYLYJ’LEY ELY SEGL’Y YCR YYYE PRCYCYGE
`
`{_ LLLLLLLUL:
`2 3WW
`
`Y....-§EYYYYY.?Y.......Y” “ ”‘2‘:
`
`EEC; LEE
`
`"o
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 10 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 10 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 8 of 16
`
`US 8,457,988 B1
`
`....................................................................................................
`CPCPE PEPEPRPEREEPC EPERE R PREPPEP PS PPEEPPP'SCPRE} CPEP
`C‘CEREEPRUCEC .R RECBURSEE‘PE‘E SPEC?REESE PEPERPES_
`PPE RECRC PEECCP;RP ECPEEP E’PREPPEP PEEP} ERRES RP
`RPPEPRPECPE PEEQCESE PEPPERPC PPCEEC ECEE PEPE “RPEPEE
`
`
`PEPE PRPRRE/EEEPREBCEESEREECP SPECPRESSP EECCERPEPEPS
`PE CHEFS PPPRP REP REPPPCRPPCP PPR“; BEER PPECPESPEEP
`ECROUCH EECRC
`
`P
`
`
`
`PPCEEC EPREPS R ERR}: RPP‘EPCRPPCP PC PEPE
`PRESPRESS CRY“WNW‘:
`PERPEEPEE PEPPER?
`E
`
`
`
`
`
` x I ES
`:
`-
`x PEPE “RN
`~;------------------------
`mifiyf~
`WEW,W I W
`{P33
`l-
`343
`1” 33:33 333333RR 3333933333 333333:3 PEPE j i
`3333 333333:33:33 333::33 33.3: ‘‘‘‘‘‘E
`
`3
`
`33:333: .333 33333. R 3331-3333 33 333 PRBPCRPPPPG "3
`
`P................ RPPPPPERCERJERP.PRRRPEEERQCPR.....
`550
` m
`W
`P
`RP PRPPE‘EI’PEPRPPRSE‘RERE SPEP‘ERCCE SUCRPPPS R
`CCR’VRCE RPP’PC‘P’RE ECPERP PC PEPE PCRCRERC‘P EERRP R:-
`RJPEERRPCP PEER? EPPE CREPERP CR3 BEER RPPEECP’EC
`
`=
`FCC ”CREPREP PEEPECCCPP RCPEC
`
`
`323:" 33333 3:33 “33:33 3: PCP
`"MW
`
`-------------2“"~'“““
`“ «
`{Ma 3. “ii."w}; EEOC)
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 11 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 11 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 9 of 16
`
`US 8,457,988 B1
`
`NJ}
`
`WK KKK EHE‘ KKKCKK 0? E’EEKEKEL‘K "MK55237
`:KKKKC-KK E00 THE KKKK3 KKUKKKKKKKKI
`\ WEEK‘KEKR=~~CE\E KKKKKKK
`l/
`\
`KKK KKKKKKKKK EK‘KKKKKKK f
`
`
`
`55 EEJECEEEKSE 0RE3EEK ES {‘KEE‘EEEEEEE} E00 EEE
`EEE‘K’E0E0???”W‘KEEEREEE E0 0EE500000000
`L {40:00 55 ES WEE} E0 EEEE "0E LOE‘EERQELEE;
`“mm““w"...imumfiwI
`
`37 Q
`1;») U
`
`.0/
`
`Em
`
`L,»
`
`FEE 03E0XEE01EEE iEé‘K’i0iCES 303'F08
`iEEE E00000? EOE-E0
`E0 EEFUWG‘K
`
`w....«-"‘
`
`
`
`EKKKKKK HEN}?
`EEEEEQEEEKXEJ""""""""""""”K7350
`KKKKKKKKKKKKKKKKKKKKK8;MM8
`$-
`.....................................................................
`
`EEMKKRAK‘LE 00.03
`
`
`
`3’40
`
`EEE‘,
`
`”E
`
`r):'-;-L
`
`’63“
`
`
`"1
`
`E03EEEK?"
`
`E
`
`.RESETEPEE03 :33" EE?’\EKEK\
`
`
`£3
`MEE‘EE E'EEKEE
`................................................................................
`(ME!",5 M EEESCRE E1003 E?
`
`
`
`w.)
`=00E0§ 5 u- ERESCEEE'0';3030 '3? EEEQUEE‘K‘C‘E’
`
`E810
`
`Vk/U
`
`3.9K]
`
`
`
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 12 of 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 12 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 10 of 16
`
`US 8,457,988 B1
`
`WE’VECAAAH‘‘A‘A ANA: M2.0WN‘ A112.SA‘A
`
`AAMAAAA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,i..............T
`AAAAAAAAAAAAAAA;
`Rim 8.133138
`
`
`
`A; ................................. ,...............................AAAAAAA ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
`
`
`
`
`=
`
`i
`
`
`
` :" {“A‘A’AA‘AW::::888188."
`
`.A AA; AAA AAA: AAA :2 AAA: AA A AAAAAA AAA
`..
`=
`--
`;
`3; AAAAAAA AA A A {AAAAAA AAA AAAA‘AA AAAAAAAAA‘A
`
`W AWE:
`______________ i............. f_____________
`WWWWWWWWWWW WWWWAWWWWWNWWWWW...W.W W‘WWWNWWW..W.A..................W}
`.3: $8138 BC};
`-
`:
`'
`"
`I; 3% {xfiifiiwffiA? AAAAAAAA isiggqimiwi
`-
`i
`
`
`“ AAAAAA: AAA: AAA: AA‘AHAAW AA
`A
`A:
`
`:,.
`{Ii-3% Ag“? 8: :‘a: §
`4‘
`
`'
`AW AAAAKEIAAA’ AAA AAA BEA‘WAAEAAAAAA;
`
`
`
`
`
`
`
`
`
`.A AAAAAA AtA AAAA AAAAAA:
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 13 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 13 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 11 of 16
`
`US 8,457,988 B1
`
`PATENT ASSiEZTANCE APPLECATiON REQUEQ? EGRM
`
`1 11300
`
`)
`497""
`
`WE:
`
`3‘3:
`E8118:
`
`$381818? ASSSWCE 8888833831011
`SE33
`
`FAX 7‘:
`
`28343982231
`
`PLEASE SE88- A XYREH P711181? ASSiSTniHCE 98888813 898118873811 1L:
`
`9.518%? NAHE
`
`,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
`
`ABHRESS._______________________________________________
`
`,
`
`_____ .8
`
`_ W
`
`
`
`PARENT SGSEGE:
`
`...... {88785.8} REESE MEL E08 A THEN. BGSAGE bf {GR-51113)
`
`.“__.18GHLES {EHREE 1113731543 SWPEY)
`
`EACKGRQUNE 183361281868:
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 14 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 14 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 12 0f 16
`
`US 8,457,988 B1
`
`SENST‘W
`
`:DPUG P"\TEE T‘é‘T 33338333“: PET"CPATVT
`332522832333
`
`3201631332 REQUEST E'Gix
`
`2"
`
`3 TDD
`
`$$é$$i$$
`
`“
`
`33332222
`
`2
`
`RAT-"E
`53,21;TfTTEJGT
`33,135,333:
`3323,2133:
`
`PATENT EETGTTT’TATTQE
`{PEST NAETEXTAST $33.3?)
`
`{AQEREES 3%
`
`{ATTE’AESS 2:2
`
`<CT3‘3', STATE ZTP £3383“)
`
`P-ITGT‘TE: <:233'35{338-
`838:
`353.{23,233.333333}
`33$; 1232458389
`DRUG 23332333333 3338233
`
`
`
`“““
`3333
`5333232 33333 33
`
`
`EATTEWTGTT TTA‘TE:
`EXPTE’AT133$ {TATE
`
`333333“. BATE:
`
`
`
`3333223303322
`
`.. 33.23: 23323
`3322335 :>
`
`32.233333 2>
`
`33:22:. 32323:
`
`.32 332523
`
`ETETTTE: 4234333433313
`
`TEES? SHTPTTET‘TT T338 YEAR
`
`
`
`*“PTTATTTTATZT USE-Em
`
`WWW} _
`T.................................................................
`
`3933) {if}?
`232325-233ww-333333-3323>3*3:A:w~22MM>33333333333333333333333333
`
`{32.22.32 {3222)
`
`EETETTTETTTEETTTTEEEE
`(REST NATEKTAST TTAETE)
`431333933 3}
`
`{2333333333 2.\
`
`<CTTY STATE 23? STATE”;
`
`MET <32.32:523’33:}
`{2353:3133223380
`233*: T23356.289
`
`
`32333112533533: 30333
`
`
`BETTE;
`XYTTETTT Tfifimi 3T3
`
`
`
`flEGTTE
`
`
`33318923353ETETATPTT
`RVTTV5812T‘T T331333.)
`
`33>
`22:258333E3‘3
`(33333133qu
`
`4335', STATE ET? (3333:}
`
`PSTGT‘TE: <323~T§8w738§8
`
`
`CASH
`
`E32333 SBTETTETTT T1333 YEAR
`
`
`
`33333332333913 BATE:
`3233::
`
`EXPTRATTTTTT
`ESE-UT: BATE:
`
`AEPTTCT’ETT
`
`{53ng’20:}?
`{TSfSTf"f{163}
`MM,2.31.31
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 15 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 15 of 27
`
`

`

`US. Patent
`
`Jun. 4, 2013
`
`Sheet 13 of 16
`
`US 8,457,988 B1
`
`3”?33??»E {ENEECirSWEEKN' ..
`
`IEfEEEEESCME—I
`
`{E} EEEE‘ ECKE \EEE,3
`
`FAYEEN'E EEEFQRMAESQN
`
`mes:
`
`, E
`
`BRUCE BEING PRESCREBEB: XYREM
`
`NRC,»'E‘IIEEEEEE E88 EEEEE'CEE SEEK; E3 85?E‘G RiESE,»IEESEEE;1
`
`E84}: ................................................
`
`EIEEYSECEK
`
`EEEEGREEAE‘EQEE
`
`Rire'EISEEINNS WEE {PEE’ESE RREREE:
`
`______________________________________________________________________
`
`SEE-KSE Ee’eis‘. EEEIE’» SE§3§E§EE ERIE?» ”M“?' REEEGEEEEI E?853'?-E?e‘E EEEE ME?»8}
`
`Er???
`
`E22
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 16 0f27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 16 of 27
`
`

`

`U.S. Patent
`
`Jun. 4, 2013
`
`Sheet 14 0f 16
`
`US 8,457,988 B1
`
`...-uu...l!..l.....u.\.!!l....!l.iE.
`5.x.x,5.m,.
`
`
`
`
`
`....A..\.......
`
`“‘
`
`~»
`
`“h... “hm“.“v.
`
`
`
`
`
`“5555555555555........5555......................................................................................
`
`
`
`éfigEmmmmmwowmmm,w
`
`mmwmwwwfim
`
`
`“41992..:2;
`..).Caz.”3
`(i.I..w:5
`bw.
`
`...... .......r.......
`
`>3w§3ivR,E33:..mEduc«ax533:
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 17 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 17 of 27
`
`
`
`
`
`

`

`U.S. Patent
`
`Jun. 4, 2013
`
`Sheet 15 of 16
`
`US 8,457,988 B1
`
`
`
`9:?«mm
`
`QLOx.
`
`
`
`
`
`2%.stEta
`
`
`
`
`
`-.-.uu.~uiu.uuu.u.-uuuuulu.u.lllllIn..u..\...nr.n:.....n.i.nI.Ininn.In.-n:.nnnnnn.i.innxun\nu:(n
`
`“
`
`m\wmgzmp.
`
`“QC
`
`
`
`a2..Em
`
`
`
`mmwfv~Lix¢.ummiun
`V23.3.?
`
`3%
`
`
`
`
`
`
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 18 0f 27
`
`AMN 1001
`CBM of U.S. Patent No. 8,457,988
`Page 18 of 27
`
`
`
`
`
`

`

`U.S. Patent
`
`Jun. 4, 2013
`
`Sheet 16 of 16
`
`US 8,457,988 B1
`
`‘
`
`
`
`3:3.“mm)5w.i.“QfikaM(g
`
`AMN 1001
`
`CBM 0fU.S. Patent No. 8,457,988
`
`Page 19 0f 27
`
`1
`
`”x.l...l.€....€......:
`
`_._.._+.“
`
`iw»
`
`“w